Search

Cookies

We use cookies to improve your experience. By continuing, you accept our use of cookies.

Business

Indian Specialty Chemical Firms Cut Capex Amid Margin Pressure, Weak Exports: Crisil

· · 3 min read

Indian specialty chemical manufacturers are scaling back capital expenditure to Rs 16,500 crore this fiscal, according to Crisil Ratings. The move comes as weak exports, rising raw material costs, and intense Chinese competition erode operating margins.

India's specialty chemical manufacturers are projected to significantly moderate their capital expenditure (capex) this financial year, with investments expected to total around Rs 16,500 crore. This reduction, highlighted in a recent Crisil Ratings report, is a direct response to mounting profitability pressures driven by subdued export demand, elevated raw material costs linked to crude oil, and aggressive pricing strategies from Chinese competitors.

Profitability Under Strain

Crisil anticipates a contraction in the industry's operating margins by 150-200 basis points, bringing them down to 14-14.5% from approximately 16% in the previous year. This squeeze on profitability is particularly acute for exports, which typically yield higher margins and constitute roughly one-third of the sector's total revenue. The inability to fully pass on increased crude-linked raw material costs in international markets exacerbates this challenge.

Despite these headwinds, the ratings agency forecasts a moderate revenue growth of about 6% for the sector this fiscal year, a decrease from the 8% recorded in each of the preceding two years.

Domestic Resilience vs. Export Weakness

Domestic demand remains a crucial growth driver for Indian specialty chemical firms. Sectors such as agrochemicals, dyes and pigments, and flavors and fragrances are expected to maintain firm demand, providing a baseline for industry revenue growth of 7-8%.

However, overall growth is being tempered by muted exports, stemming from global supply chain disruptions and cautious procurement by international buyers. Anuj Sethi, Senior Director at Crisil Ratings, noted that while exports remain subdued, trade flows could normalize within the next couple of quarters if geopolitical tensions, particularly in West Asia, continue to ease. He also pointed out that China's reduction in export incentives for certain products might offer some pricing support, though persistent dumping could limit substantial gains.

Navigating Input Costs and Competition

Crude-linked inputs, which account for nearly one-third of raw material costs, continue to impact profitability. Poonam Upadhyay, Director at Crisil Ratings, indicated that a recent softening in crude and chemical input prices should help cap the decline in operating margins. Nevertheless, intense Chinese competition will restrict pricing flexibility, and global supply chains may take several quarters to fully stabilize.

The impact of these pressures will vary among manufacturers. Companies heavily reliant on ethylene and propylene face greater vulnerability due to their higher exposure to crude prices. In contrast, producers utilizing benzene, toluene, and xylene (BTX)-based inputs may fare better, particularly those focused on value-added products. Firms specializing in fluorine-based chemistries are expected to demonstrate relative resilience, benefiting from their niche market positions and stronger ability to pass on costs.

While recent customs duty exemptions on select petrochemical inputs offer some relief, Crisil suggests they are unlikely to fully offset the broader volatility in input costs.

Strategic Recalibration and Financial Outlook

In response to these market conditions, specialty chemical firms are recalibrating their capital spending strategies. Investments are now primarily directed towards backward integration, import substitution initiatives, and the development of niche chemistries. Most manufacturers plan to finance these investments through internal accruals.

However, lower earnings and increased working capital requirements are anticipated to strain balance sheets. Crisil projects the industry's debt-to-EBITDA ratio to rise to approximately 2.2 times this fiscal, up from 1.9 times last year. Concurrently, interest coverage is expected to decline to about 6 times from 7.5 times, reflecting the combined impact of weaker profitability and higher working capital needs.

The sector's performance in the coming quarters will hinge on several critical factors: the pace of recovery in export demand, any easing of Chinese pricing pressure, movements in feedstock costs, and the ability of companies to restore margins through selective price adjustments.

Related